Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 29, 2014

Primary Completion Date

April 10, 2018

Study Completion Date

April 10, 2018

Conditions
VitiligoPiebaldism
Interventions
DEVICE

VITICELL

graft of autologus cells (kaeratonicytes and melanocytes) obtained after trypsinization of thin skin biopsy resuspended into hyaluronic acid

DEVICE

PLACEBO

hyaluronic acid alone

Trial Locations (5)

Unknown

Department of Dermatology - Ghent University Hospital, Ghent

University Hospital Center of Bordeaux, Bordeaux

CHU Le Mans, Le Mans

Dr Michel PASCAL, Paris

San Gallicano Dermatological Institute, Roma

Sponsors
All Listed Sponsors
lead

Laboratoires Genévrier

INDUSTRY

NCT02156427 - Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism | Biotech Hunter | Biotech Hunter